Robbie L. McLeod
Neurobiology-Respiratory
Schering-Plough Research Institute
Kenilworth
NJ 07033-0539
USA
Name/email consistency: high
- Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models. McLeod, R.L., Tulshian, D.B., Bolser, D.C., Varty, G.B., Baptista, M., Fernandez, X., Parra, L.E., Zimmer, J.C., Erickson, C.H., Ho, G.D., Jia, Y., Ng, F.W., Korfmacher, W., Xu, X., Veals, J., Smith-Torhan, A., Wainhaus, S., Fawzi, A.B., Austin, T.M., van Heek, M., Hey, J.A. Eur. J. Pharmacol. (2010)
- Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion. McLeod, R.L., Mingo, G.G., Xu, X., Palamanda, J., Hunter, J.C., Jia, Y. Am. J. Rhinol. Allergy (2009)
- Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough. McLeod, R.L., Tulshian, D.B., Ho, G.D., Fernandez, X., Bolser, D.C., Parra, L.E., Zimmer, J.C., Erickson, C.H., Fawzi, A.B., Jayappa, H., Lehr, C., Erskine, J., Smith-Torhan, A., Zhang, H., Hey, J.A. Pharmacology (2009)
- TRPV1 antagonists as potential antitussive agents. McLeod, R.L., Correll, C.C., Jia, Y., Anthes, J.C. Lung (2008)
- Sulfur-dioxide exposure increases TRPV1-mediated responses in nodose ganglia cells and augments cough in guinea pigs. McLeod, R.L., Jia, Y., McHugh, N.A., Fernandez, X., Mingo, G.G., Wang, X., Parra, L.E., Chen, J., Brown, D., Bolser, D.C., Kreutner, W., Hey, J.A. Pulm. Pharmacol. Ther (2007)
- TRPV1 antagonists attenuate antigen-provoked cough in ovalbumin sensitized guinea pigs. McLeod, R.L., Fernandez, X., Correll, C.C., Phelps, T.P., Jia, Y., Wang, X., Hey, J.A. Cough. (london,. England) (2006)
- Effect of combined histamine H1 and H3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80. McLeod, R.L., Mingo, G.G., Kreutner, W., Hey, J.A. Life Sci. (2005)
- Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687). McLeod, R.L., Rizzo, C.A., West, R.E., Aslanian, R., McCormick, K., Bryant, M., Hsieh, Y., Korfmacher, W., Mingo, G.G., Varty, L., Williams, S.M., Shih, N.Y., Egan, R.W., Hey, J.A. J. Pharmacol. Exp. Ther. (2003)
- Antitussive effect of nociceptin/orphanin FQ in experimental cough models. McLeod, R.L., Bolser, D.C., Jia, Y., Parra, L.E., Mutter, J.C., Wang, X., Tulshian, D.B., Egan, R.W., Hey, J.A. Pulm. Pharmacol. Ther (2002)
- Characterization of nasal obstruction in the allergic guinea pig using the forced oscillation method. McLeod, R.L., Young, S.S., Erickson, C.H., Parra, L.E., Hey, J.A. J. Pharmacol. Toxicol. Methods (2002)
- Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors. McLeod, R.L., Parra, L.E., Mutter, J.C., Erickson, C.H., Carey, G.J., Tulshian, D.B., Fawzi, A.B., Smith-Torhan, A., Egan, R.W., Cuss, F.M., Hey, J.A. Br. J. Pharmacol. (2001)
